CDCP1 and neoplasm: To explore whether the ability of anti-CDCP1 mAbs to induce rapid internalization and degradation of CDCP1 can be further exploited against cancer cells, we examined the effectiveness of conjugated forms of 10D7 as agents for PET imaging of cancer in vivo, and inhibition of cell proliferation in vitro and tumor growth in vivo.